Publications by authors named "Koen Bezemer"

Claim this Profile
R
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer.
Songul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg, Ferry A L M Eskens, Marjolein Y V Homs, Koen Bezemer

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer.
Freek R van 't Land, Marcella Willemsen, Koen Bezemer, Sjoerd H van der Burg, Thierry P P van den Bosch

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 study.
Joachim G Aerts, Robert Belderbos, Paul Baas, Arnaud Scherpereel, Koen Bezemer

Lancet Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma.
Mandy van Gulijk, Bob Belderbos, Daphne Dumoulin, Robin Cornelissen, Koen Bezemer

Int J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials.
Daphne W Dumoulin, Robin Cornelissen, Koen Bezemer, Sara J Baart, Joachim G J V Aerts

Vaccines (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma.
Heleen Vroman, Giulia Balzaretti, Robert A Belderbos, Paul L Klarenbeek, Menno van Nimwegen, Koen Bezemer

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients.
Pauline L de Goeje, Myrthe Poncin, Koen Bezemer, Margaretha E H Kaijen-Lambers, Harry J M Groen

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy.
Lisanne Noordam, Margaretha E H Kaijen, Koen Bezemer, Robin Cornelissen, Lex A P W M Maat

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human.
Joachim G J V Aerts, Pauline L de Goeje, Robin Cornelissen, Margaretha E H Kaijen-Lambers, Koen Bezemer

Clin Cancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer.
Pauline L de Goeje, Egbert F Smit, Cynthia Waasdorp, Merel T B Schram, Margaretha E H Kaijen-Lambers, Koen Bezemer

Am J Respir Crit Care Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.
Floris Dammeijer, Lysanne A Lievense, Margaretha E Kaijen-Lambers, Menno van Nimwegen, Koen Bezemer

Cancer Immunol Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.
Lysanne A Lievense, Koen Bezemer, Robin Cornelissen, Margaretha E H Kaijen-Lambers, Joost P J J Hegmans

Lung Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression.
Lysanne A Lievense, Robin Cornelissen, Koen Bezemer, Margaretha E H Kaijen-Lambers, Joost P J J Hegmans

J Thorac Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.
Robin Cornelissen, Joost P J J Hegmans, Alexander P W M Maat, Margaretha E H Kaijen-Lambers, Koen Bezemer

Am J Respir Crit Care Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.
Pauline L de Goeje, Koen Bezemer, Marlies E Heuvers, Anne-Marie C Dingemans, Harry Jm Groen

Oncoimmunology· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.
Marlies E Heuvers, Femke Muskens, Koen Bezemer, Margaretha Lambers, Anne-Marie C Dingemans

Lung Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis